A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics
Clinical trial NCT02953639 · COMPLETED
Trial details
- NCT number
- NCT02953639
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-30
- Primary completion
- 2019-12-12
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.